U.S. MEIBOMIAN GLAND DYSFUNCTION MARKET ANALYSIS

Market Challenges And Opportunities

U.S. Meibomian Gland Dysfunction Market – Driver

• Increasing prevalence of meibomian gland dysfunction syndrome: Increasing prevalence of meibomian gland dysfunction syndrome is expected to propel the growth of the U.S. meibomian gland dysfunctions market over the forecast period. For instance, according to a study published by the American Optometric Association in 2021, more than 16 million Americans, including twice as many women than men, were suffering from dry eye disease, and out of them around 70% of patients had meibomian gland disease. Moreover, according to the Fellow of the American College of Surgeons in January 2020, meibomian gland disease (also referred to as evaporative dry eye), is one of the most common causes of dry eyes across the globe. An estimated 50 to 70% of the elderly population has some degree of dry eye and nearly 70% of dry eye involves at least some degree of meibomian gland disease.
• Increasing excess usage of computers and mobile screens: The increasing excess usage of computers and mobile screens is expected to increase the incidence of meibomian gland dysfunction over the period of time and is also expected to aid in the growth of the market. People who frequently use computers or video screens are at high risk of developing meibomian gland dysfunction, as using screens for a long duration can lead to reduced blinking and tear production. Digital device usage has increased significantly in recent years among all age groups, due to extensive use for social and professional purposes. For instance, an article published in the National Library of Medicine Journal in March 2020, reported blue light emitted by digital screens can lead to symptoms of dry eyes which cause meibomian gland dysfunction. Exposure to blue light (range of 400–500 nm) can be harmful to the retina. Longer duration and less intense light exposure can also induce photochemical damage in the eyes.

U.S. Meibomian Gland Dysfunction Market: Restraint

Potential side effects of drugs

Potential side effects of drugs, such as steroids, used in the treatment of meibomian gland dysfunction syndrome have a wide range of side effects on the body of the patient who is continuously taking more than the prescribed dose of steroids for a longer period. This is expected to restrain the market growth during the forecast period. For Instance, according to an article published in the National Library of Medicine on April 05, 2023, Reported T-cell activation, immune checkpoint inhibitors are associated with multiple immune-related adverse events, one of which is immune checkpoint inhibitor-induced sicca syndrome. Exocrine gland damage leading to dry mouth and dry eyes were reported as adverse events following the use of nivolumab, durvalumab, and pembroliuzmab. Rheumatic complications were well reported in the literature, especially with regard to the sicca symptoms.